Large-scale testing (Phase 3)Study completedNCT01782937What this trial is testingAn Open-label, Non-controlled Study of KHK4827 in Subjects With PsoriasisWho this might be right forPsoriasis Kyowa Kirin Co., Ltd. 30
Post-approval studies (Phase 4)Study completedNCT04183881What this trial is testingClinical Study of BrodalumabWho this might be right forPsoriasis VulgarisPsoriatic ArthritisPustular; Psoriasis, Palmaris Et Plantaris+1 more Kyowa Kirin Co., Ltd. 138
Post-approval studies (Phase 4)Ended earlyNCT06042920What this trial is testingEvaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital PsoriasisWho this might be right forPalmoplantar PsoriasisGenital Psoriasis Bristol-Myers Squibb 130
Not applicableUnknownNCT01952275What this trial is testingObservational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin DiseasesWho this might be right forOther Specified Inflammatory Disorders of Skin or Subcutaneous TissuePyoderma GangrenosumErosive Pustular Dermatosis of the Scalp+25 more University of Zurich 600
Large-scale testing (Phase 3)Study completedNCT03022045What this trial is testingAssess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic PsoriasisWho this might be right forPsoriasis AbbVie 18
Not applicableStudy completedNCT05670821What this trial is testingPMS of Spesolimab I.V. in GPP Patients With Acute SymptomsWho this might be right forGeneralized Pustular Psoriasis Boehringer Ingelheim 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT03886246What this trial is testingEffisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous StudyWho this might be right forGeneralized Pustular Psoriasis Boehringer Ingelheim 131
Large-scale testing (Phase 3)Active Not RecruitingNCT06323356What this trial is testingTAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic PsoriasisWho this might be right forGeneralized Pustular PsoriasisErythrodermic Psoriasis Takeda 18
Large-scale testing (Phase 3)Study completedNCT05239039What this trial is testingAn Expanded Access Program in China to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment OptionsWho this might be right forGeneralized Pustular Psoriasis Boehringer Ingelheim 39
Not applicableStudy completedNCT07428915What this trial is testingEvaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and DermatologistsWho this might be right forPustular Psoriasis (PP)Generalized Pustular Psoriasis (GPP)Eczema Atopic Dermatitis+11 more AI Labs Group S.L 15
Large-scale testing (Phase 3)Study completedNCT03998683What this trial is testingGuselkumab for the Treatment of Palmoplantar-non-Pustular PsoriasisWho this might be right forPsoriasis Janssen-Cilag Ltd. 117
Not applicableStudy completedNCT07428941What this trial is testingEvaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.Who this might be right forSkin LesionsMelanocytic NeviMelanoma (Skin Cancer)+6 more AI Labs Group S.L 9
Testing effectiveness (Phase 2)Study completedNCT04399837What this trial is testingTest Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular PsoriasisWho this might be right forGeneralized Pustular Psoriasis Boehringer Ingelheim 123
Large-scale testing (Phase 3)Looking for participantsNCT06477536What this trial is testingLong-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular PsoriasisWho this might be right forGeneralized Pustular Psoriasis Shanghai Huaota Biopharmaceutical Co., Ltd. 33
Testing effectiveness (Phase 2)Study completedNCT00301002What this trial is testingStudy to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar PustulosisWho this might be right forPsoriasisPalmoplantaris PustulosisPustular Psoriasis of Palms and Soles+2 more The Guenther Dermatology Research Centre 15
Not applicableNot Yet RecruitingNCT07448428What this trial is testingGeneralized Pustular Psoriasis Registry in Costa RicaWho this might be right forGeneralized Pustular PsoriasisGeneralized Pustular Psoriasis (GPP) Caja Costarricense de Seguro Social 50
Early research (Phase 1)Study completedNCT05512598What this trial is testingHB0034 in Patients With Generalized Pustular Psoriasis (GPP)Who this might be right forGeneralized Pustular Psoriasis Shanghai Huaota Biopharmaceutical Co., Ltd. 9
Post-approval studies (Phase 4)Study completedNCT03942042What this trial is testingIxekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic PsoriasisWho this might be right forGeneralized Pustular PsoriasisErythrodermic Psoriasis Eli Lilly and Company 12
Not applicableStudy completedNCT05215561What this trial is testingSpecial Drug Use-results Survey to Evaluate Safety and Efficacy of Cosentyx in Pediatric Patients With PsV, PsA, or GPPWho this might be right forPsoriasis VulgarisPsoriatic ArthritisPustular Psoriasis Novartis Pharmaceuticals 36
Not applicableLooking for participantsNCT06100991What this trial is testingCorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness RegistryWho this might be right forGeneralized Pustular Psoriasis CorEvitas 200